GGrantIndex
Sort

23,748 grants matching melanoma

Restoration of Tumor Suppression Activity in Malignant Melanoma

$497,921
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2009 · CA

DKK2 regulates NK activation and tumor immunity

$497,913
Dianqing Wu · Yale University · R01 · FY2019 · CA

Core A: Curation and Statistical Analysis Core

$497,890
Katherine S Panageas · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA

Core A: Curation and Statistical Analysis Core

$497,890
Katherine S Panageas · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA

Regulators of Cancer Immunotherapy Response

$497,881
Xiaole Shirley Liu · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Identification of 9p and 20q Germline Alterations in Glioblastoma Pathogenesis

$497,797
Robert B. Jenkins · Mayo Clinic Rochester · RC1 · FY2009 · NS

Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer

$497,774
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

Rare Cancer Genetics Registry

$497,727
Dianne M Finkelstein · Massachusetts General Hospital · R01 · FY2016 · CA

Validation of circulating tumor DNA assays for detection of metastatic melanoma

$497,571
David Polsky · New York University School Of Medicine · UH3 · FY2020 · CA

Mechanisms of uveal melanoma dormancy and targeted therapy tolerance

$497,523
Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA

RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING

$497,424
Prabhas V Moghe · Rutgers, The State Univ Of N.J. · R01 · FY2015 · EB

DISPLAY METHODS FOR SURVEYING MUTATIONS

$497,323
Yale University · R33 · FY2002 · CA

The Development of the Domestic Cat, <I>Felis catus<I>, as an A

$497,286
Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

The Development of Thermally-activated Metalloenediynes for Cancer Therapy

$497,268
Joseph R Dynlacht · Indiana University Indianapolis · R01 · FY2017 · CA

Personalized Immunotherapy of Patients with Ovarian Cancer

$497,223
Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA

Making and breaking CD8+ T cell self-tolerance

$497,181
Stephen C Jameson · University Of Minnesota · R01 · FY2018 · AI

Rare Cancer Genetics Registry

$497,179
Dianne M Finkelstein · Massachusetts General Hospital · R01 · FY2015 · CA

MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM

$497,024
Mobile Infirmary Medical Center · U10 · FY2002 · CA

Restoration of Tumor Suppression Activity in Malignant Melanoma

$496,909
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2006 · CA

Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death

$496,811
Clifford Cho · Van Andel Research Institute · R01 · FY2025 · CA

Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen

$496,790
Antoni Ribas · California Institute Of Technology · P01 · FY2014 · CA

Restoration of Tumor Suppression Activity in Malignant Melanoma

$496,770
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2010 · CA

Applications of ultrahigh-speed long-range wide-field OCT in anterior eye diseases

$496,687
David Huang · Oregon Health & Science University · R01 · FY2019 · EY

Molecular Epidemiology of Melanoma

$496,652
University Of Pennsylvania · R01 · FY2005 · CA

Manipulating Lipid Metabolism to Reverse Immune Dysfunction in Solid Cancers

$496,391
Jessica E Thaxton · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA